We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immune Cells Linked to Malaria-Induced Anemia Through Autoantibody Production

By LabMedica International staff writers
Posted on 28 Nov 2019
Print article
Image: Photomicrograph of a blood smear that revealed the presence of numerous Plasmodium falciparum ring-form parasites. Note that some red blood cells (RBCs) contain multiple parasites. Anemia is a common and sometimes deadly complication of malaria infections (Photo courtesy of Centers of Disease Control and Prevention/Dr. Greene).
Image: Photomicrograph of a blood smear that revealed the presence of numerous Plasmodium falciparum ring-form parasites. Note that some red blood cells (RBCs) contain multiple parasites. Anemia is a common and sometimes deadly complication of malaria infections (Photo courtesy of Centers of Disease Control and Prevention/Dr. Greene).
Malaria is still a major global health threat with over 200 million new infections and around 400,000 deaths per year. Anemia is a common complication associated with malaria that contributes significantly to the great morbidity and mortality associated with the disease.

Despite its high clinical relevance, the mechanisms underlying malarial anemia in patients remain largely unknown. The difficulty in studying this syndrome arises at least in part from its multi-factorial etiology, as malaria causes both the clearance (through complement-mediated lysis or phagocytosis) of infected and uninfected erythrocytes and bone marrow dyserythropoiesis.

An international team of scientists led by those at New York University School of Medicine (New York City, NY, USA) recruited 24 patients who were aged between 18 and 65 years, and a diagnosis of Plasmodium falciparum malaria by microscopy. This cohort suffered from mild anemia with average hemoglobin levels of 12.4 g/dL (males) and 10.2 g/dL (females). Plasma and peripheral blood mononuclear cells (PBMC) were isolated from peripheral venous blood by Ficoll purification and stored at −80 °C until temperature-controlled transportation from Germany to the New York University. Peripheral venous blood from healthy malaria-naïve donors was obtained on the day of the study.

The scientists performed flow cytometry on a FACSCalibur (Becton Dickinson, Franklin Lakes, NJ, USA) and analyzed with FlowJo (Tree Star, Ashland, OR, USA). Intracellular T-bet staining was performed using the True-Nuclear Transcription Factor Buffer Set (Biolegend, San Diego, CA, USA). Enzyme-linked immunosorbent assays were performed to estimate malarial antibodies. Assessment of the erythrocyte lysis capacity of plasma was performed following previously described methods with small modifications. Supernatants were read in a spectrophotometer at 414 nm to assess erythrocyte lysis. ELISPOTs were performed as previously reported.

The team identified the production of an unusual type of immune B-cell: FcRL5+T-bet+ B-cells, that increases anti-phosphatidylserine (PS) antibody production associated with the development of anemia in the patients. These immune cells also developed and produced anti-PS antibodies in blood drawn from uninfected people that was then exposed to broken remnants of malaria-infected red blood cells in the laboratory.

Ana M. Rodriguez, PhD, a Professor of Microbiology and a senior author of the study, said, "There is a great need for novel targeted treatments for malaria-induced anemia, which is common and can be fatal for many malaria patients. The unique phenotype and specificity of these immune B-cells could allow them to be used as a biomarker for anemia or as a target for new therapies.” The study was published on November 12, 2019 in the journal eLife.

Related Links:
New York University School of Medicine
Becton Dickinson
Tree Star
Biolegend


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.